Today, ProMetic Life Sciences’ (PLI) “Outperform” Rating Reaffirm at Royal Bank Of Canada

Short resume:

news
90%
stock
80%
reaffirmed
80%
outperform
70%
Today, ProMetic Life Sciences' (PLI) “Outperform” Rating Reaffirm at Royal Bank Of Canada

Royal Bank Of Canada reiterated their outperform rating on shares of ProMetic Life Sciences Inc. (TSE:PLI) in a research report sent to investors on Tuesday morning, StockTargetPrices.
Source DailyQuint
Read More…

More News


Be the first to comment

Leave a Reply

Your email address will not be published.


*